| charlson comorbidity index |
333 |
| comorbidities |
333 |
| rheumatic disease comorbidity index |
333 |
| spondyloarthritis |
333, 347 |
| biostar |
333 |
| hbv |
347 |
| hcv |
347 |
| rheumatic diseases |
347, 419 |
| rheumatoid arthritis |
347 |
| treasure |
347 |
| viral hepatitis |
347 |
| viral reactivation |
347 |
| juvenile idiopathic arthritis |
358 |
| juvenile rheumatoid arthritis |
358 |
| pericardial effusion |
358 |
| tamponade |
358 |
| connective tissue disease |
367 |
| enzyme-linked immunosorbent assay |
367 |
| lung interstitial disease |
367 |
| matrix metalloproteinase |
367 |
| depression |
375 |
| fatigue |
375 |
| fibromyalgia |
375 |
| sjögren’s syndrome |
375 |
| cartilage diseases |
387 |
| correlation of data |
387 |
| knee |
387 |
| muscle strength dynamometer |
387 |
| osteoarthritis |
387 |
| physical functional performance |
387 |
| antineutrophil cytoplasmic antibodies |
397 |
| rituximab |
397 |
| vasculitis |
397 |
| autoimmune diseases |
406 |
| hemophagocytic syndrome |
406 |
| macrophage activation syndrome |
406 |
| antibody formation |
419 |
| coronavac vaccine |
419 |
| coronavirus disease 2019 vaccines |
419 |
| bnt162 vaccine |
419 |
| b cell-activating factor |
429 |
| sledai-2k |
429 |
| systemic lupus erythematosus |
429, 468 |
| autonomic nervous system |
441 |
| familial mediterranean fever |
441 |
| peripheral nervous system |
441 |
| sympathetic skin response |
441 |
| clinical practice |
451 |
| microcirculation |
451 |
| nailfold capillaroscopy |
451 |
| recommendations |
451 |
| sting–associated vasculopathy with onset in infancy |
461 |
| tofacitinib |
461 |
| v194l mutation |
461 |
| egyptian patients |
468 |
| mortality |
468 |
| citation: min hk |
480 |
| kim sh |
480 |
| kim hr |
480 |
| lee sh. solitary syndesmophyte in odontoid process of a patient with ankylosing spondylitis. arch rheumatol 2023 |
480 |
| 38(3):480-481 |
480 |
